Literature DB >> 2512864

Ehlers-Danlos syndrome, clotting disorders and muscular dystrophy.

P Bertin1, R Treves, A Julia, S Gaillard, R Desproges-Gotteron.   

Abstract

Ehlers-Danlos syndrome includes 11 distinct entities. The diversity of this collagen dysplasia and its combination with other abnormalities make it difficult to understand physiopathologically. A case of Ehlers-Danlos syndrome is reported, which is novel owing to its combination with clotting abnormalities and especially with muscular dystrophy. To our knowledge this has not previously been reported. The patient was a young man aged 16 years who presented with Ehlers-Danlos syndrome satisfying Perelman's diagnostic criteria. His father and two brothers had comparable clinical symptoms, but his mother and sister were healthy. The four male subjects had an increased cephalin-kaolin time, reduced levels of factor VIII and Willebrand's factor (but without haemophilia A or Willebrand's disease), and, especially, an abnormal platelet ATP secretion. The proband alone had muscular disease with bilateral quadriceps fatigability and amyotrophy. The muscle enzyme levels were greatly increased, the electromyographic trace was myogenic, and the biopsy showed severe muscular dystrophy. This new observation poses the problem of the relation between clotting abnormalities and collagen abnormalities in the Ehlers-Danlos syndrome. It is difficult to classify this case within any of the 11 known types because of its muscular manifestations. It may perhaps be a fortuitous combination or an extension of the nosological framework of this syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2512864      PMCID: PMC1003920          DOI: 10.1136/ard.48.11.953

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  Letter: Platelet aggregating properties of Ehlers-Danlos syndrome "collagen".

Authors:  U Hedner
Journal:  Thromb Diath Haemorrh       Date:  1975-04-30

Review 2.  [Hereditary deficiency in the enzymes of the biosynthesis of collagen. The Ehlers-Danlos syndromes (author's transl)].

Authors:  A Gajdos
Journal:  Nouv Presse Med       Date:  1977-10-15

3.  [Prolongation of bleeding time and collagen anomalies].

Authors:  J Caen; Y Legrand; Y Sultan; S Cronberg; C Jeanneau; G Pignaud
Journal:  Nouv Rev Fr Hematol       Date:  1970 May-Jun

Review 4.  Heritable diseases of collagen.

Authors:  D J Prockop; K I Kivirikko
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

5.  Ehlers-Danlos syndrome type IV: dramatic, deceptive, and deadly.

Authors:  R S Sparkman
Journal:  Am J Surg       Date:  1984-05       Impact factor: 2.565

6.  Platelet defect in a case of Ehlers-Danlos syndrome.

Authors:  D Onel; S B Ulutin; O N Ulutin
Journal:  Acta Haematol       Date:  1973-10       Impact factor: 2.195

7.  Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen.

Authors:  T Sasaki; K Arai; M Ono; T Yamaguchi; S Furuta; Y Nagai
Journal:  Arch Dermatol       Date:  1987-01

8.  [Arterial manifestations of the Ehlers' Danlos syndrome].

Authors:  C Beylot; P Bioulac; M S Doutre
Journal:  Ann Med Interne (Paris)       Date:  1983

9.  Ehlers-Danlos syndrome with abnormal collagen fibrils, sinus of Valsalva aneurysms, myocardial infarction, panacinar emphysema and cerebral heterotopias.

Authors:  L N Cupo; R E Pyeritz; J L Olson; S J McPhee; G M Hutchins; V A McKusick
Journal:  Am J Med       Date:  1981-12       Impact factor: 4.965

10.  A new form of Ehlers-Danlos syndrome. Fibronectin corrects defective platelet function.

Authors:  M A Arneson; D E Hammerschmidt; L T Furcht; R A King
Journal:  JAMA       Date:  1980-07-11       Impact factor: 56.272

  10 in total
  3 in total

1.  Homozygous factor V Leiden mutation in type IV Ehlers-Danlos patient.

Authors:  Marwan Refaat; Mostafa Hotait; Brion Winston
Journal:  World J Clin Cases       Date:  2014-03-16       Impact factor: 1.337

Review 2.  Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

Authors:  Marco Castori; Nicol C Voermans
Journal:  Iran J Neurol       Date:  2014-10-06

3.  Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration.

Authors:  Albert Busch; Sabine Hoffjan; Frauke Bergmann; Birgit Hartung; Helena Jung; Daniela Hanel; Andeas Tzschach; Janos Kadar; Yskert von Kodolitsch; Christoph-Thomas Germer; Heiner Trobisch; Erwin Strasser; René Wildenauer
Journal:  Orphanet J Rare Dis       Date:  2016-08-03       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.